A carregar...
Comparison of the Efficacy of Posaconazole Delayed Release Tablets and Suspension in Pediatric Hematology/Oncology Patients
OBJECTIVES: Posaconazole is effective in preventing invasive fungal infections in neutropenic pediatric patients. The oral suspension has challenges in administration and absorption that are theorized to be minimized with delayed release tablets. However, this has not been validated in the pediatric...
Na minha lista:
| Publicado no: | J Pediatr Pharmacol Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pediatric Pharmacy Advocacy Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6938289/ https://ncbi.nlm.nih.gov/pubmed/31897075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-25.1.47 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|